Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valrocemide (TV1901), also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 55.00 | |
50 mg | In stock | $ 72.00 | |
100 mg | In stock | $ 109.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Valrocemide (TV1901), also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy. |
Synonyms | TV1901, N-Valproylglycinamide |
Molecular Weight | 200.28 |
Formula | C10H20N2O2 |
CAS No. | 92262-58-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (499.30 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valrocemide 92262-58-3 Others TV1901 Inhibitor TV-1901 N-Valproylglycinamide TV 1901 inhibit inhibitor